RxDoctor Payments Data

Molly Rittenhouse, PA

Physician Assistant · Dayton, OHNPI 1447913892

Payments from drug & device makers

$2,371in general payments, 2019–2025

Across 109 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$794
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$486
  • Johnson & Johnson$284
  • Regeneron Healthcare Solutions, Inc.$142
  • Phathom Pharmaceuticals, Inc.$131
  • Bristol Myers Squibb$100
  • plus $435 from 11 others

What the payments were for

  • Food & beverage$2,371100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,371 in reported general payments places this provider in the 85th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$40,601
Medicare patients
288
Services billed
771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase23$66,999
ZenpepLipase/Protease/Amylase15$60,597
LinzessLinaclotide31$32,860
Esomeprazole Magnesium45$2,771
Mesalamine ErMesalamine12$2,420
Omeprazole145$2,112
Pantoprazole Sodium116$1,500
Dicyclomine Hcl46$775
Ondansetron OdtOndansetron30$764
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine25$739
Colestipol Hcl22$728
Famotidine56$568
Promethazine Hcl29$380
Ondansetron Hcl24$337
Nortriptyline Hcl19$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$794$99,85954 claims
Aimmune Therapeutics, Inc.Zenpep$18$60,59715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →